128 related articles for article (PubMed ID: 2076324)
1. [Effect of sodium thiosulfate on cisplatin-induced ototoxicity].
Lou WH
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1990 Aug; 25(4):208-10, 255. PubMed ID: 2076324
[TBL] [Abstract][Full Text] [Related]
2. Delayed administration of sodium thiosulfate in animal models reduces platinum ototoxicity without reduction of antitumor activity.
Muldoon LL; Pagel MA; Kroll RA; Brummett RE; Doolittle ND; Zuhowski EG; Egorin MJ; Neuwelt EA
Clin Cancer Res; 2000 Jan; 6(1):309-15. PubMed ID: 10656463
[TBL] [Abstract][Full Text] [Related]
3. Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels.
Dickey DT; Wu YJ; Muldoon LL; Neuwelt EA
J Pharmacol Exp Ther; 2005 Sep; 314(3):1052-8. PubMed ID: 15951398
[TBL] [Abstract][Full Text] [Related]
4. The effect of sodium thiosulfate on ototoxicity and pharmacokinetics after cisplatin treatment in guinea pigs.
Saito T; Zhang ZJ; Manabe Y; Ohtsubo T; Saito H
Eur Arch Otorhinolaryngol; 1997; 254(6):281-6. PubMed ID: 9248736
[TBL] [Abstract][Full Text] [Related]
5. [Effect of sodium thiosulfate on the antitumor effect and nephrotoxicity of CDDP in human gastric cancer transplanted in nude mice].
Saito D; Fujii T; Yoshida S; Ohkura H; Oguro Y
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):379-85. PubMed ID: 2930203
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacokinetic study of cisplatin and sodium thiosulfate in two-route-infusion chemotherapy].
Ikeda K
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1026-31. PubMed ID: 3963847
[TBL] [Abstract][Full Text] [Related]
7. [New treatments for urogenital toxicity of anti-neoplastic chemotherapy].
Shibuya M; Hirosawa A; Niitani H
Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 2):950-6. PubMed ID: 2111664
[TBL] [Abstract][Full Text] [Related]
8. Ototoxicity of kanamycin in albino and pigmented guinea pigs. II. A scanning electron microscopic study.
Wästerström SA; Bredberg G
Am J Otol; 1986 Jan; 7(1):19-24. PubMed ID: 3946576
[TBL] [Abstract][Full Text] [Related]
9. [cis-diamminedichloroplatinum cochlear toxicity].
Ma CL
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1990 Aug; 25(4):199-201, 254. PubMed ID: 2076321
[TBL] [Abstract][Full Text] [Related]
10. Ototoxicity of tobramycin in young adult and old rats.
Dormans JA; Peters-Volleberg GW; Dortant PM; Speijers GJ
Toxicol Appl Pharmacol; 1996 Jan; 136(1):179-85. PubMed ID: 8560472
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of combined use of sodium thiosulfate in percutaneous isolated liver chemoperfusion of cisplatin under complete hepatic venous isolated and charcoal hemoperfusion].
Kusunoki N; Ku Y; Tominaga M; Iwasaki T; Muramatsu S; Sugimoto T; Kuroda Y
Gan To Kagaku Ryoho; 1997 Sep; 24(12):1781-4. PubMed ID: 9382532
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of two-route chemotherapy using cis-diamminedichloroplatinum(II) and its antidote, sodium thiosulfate, in combination with angiotensin II in a rat limb tumor.
Kuroiwa T; Aoki K; Taniguchi S; Hasuda K; Baba T
Cancer Res; 1987 Jul; 47(14):3618-23. PubMed ID: 3594429
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the effect of acetyl L-carnitine on experimental cisplatin ototoxicity and neurotoxicity.
Gunes D; Kirkim G; Kolatan E; Guneri EA; Ozogul C; Altun Z; Serbetcioglu B; Yilmaz O; Aktas S; Mutafoglu K; Tufekci O; Erbayraktar Z; Olgun N
Chemotherapy; 2011; 57(3):186-94. PubMed ID: 21525749
[TBL] [Abstract][Full Text] [Related]
14. Dose-dependent inner ear changes after i.v. administration of cisplatin.
Laurell G; Bagger-Sjöbäck D
J Otolaryngol; 1991 Jun; 20(3):158-67. PubMed ID: 1870163
[TBL] [Abstract][Full Text] [Related]
15. [The diminishing oocyte toxicity following intraperitoneal infusion of cisplatin (CDDP) combined with subcutaneous injection of sodium thiosulfate (STS) in syngeneic young mice].
Takizawa K; Yokoo I; Shima Y; Ozaki I; Sato M; Iguchi T; Takeda Y
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Nov; 42(11):1484-8. PubMed ID: 2273302
[TBL] [Abstract][Full Text] [Related]
16. [Studies on an appropriate intra thoracic administration of cisplatin and sodium thiosulfate in malignant pleural effusion].
Kitajima K; Fukuoka M; Kusunoki Y; Negoro S; Takada M; Matsui K; Sakai N; Ryu S; Takifuji N; Masuda N
Gan To Kagaku Ryoho; 1988 Dec; 15(12):3253-9. PubMed ID: 3196043
[TBL] [Abstract][Full Text] [Related]
17. Comparison of five agents in protecting the cochlea against the ototoxic effects of cisplatin in the hamster.
Kaltenbach JA; Church MW; Blakley BW; McCaslin DL; Burgio DL
Otolaryngol Head Neck Surg; 1997 Nov; 117(5):493-500. PubMed ID: 9374173
[TBL] [Abstract][Full Text] [Related]
18. Ginkgo biloba extract (EGb 761) protects against cisplatin-induced ototoxicity in rats.
Huang X; Whitworth CA; Rybak LP
Otol Neurotol; 2007 Sep; 28(6):828-33. PubMed ID: 17450108
[TBL] [Abstract][Full Text] [Related]
19. Caspase inhibitors, but not c-Jun NH2-terminal kinase inhibitor treatment, prevent cisplatin-induced hearing loss.
Wang J; Ladrech S; Pujol R; Brabet P; Van De Water TR; Puel JL
Cancer Res; 2004 Dec; 64(24):9217-24. PubMed ID: 15604295
[TBL] [Abstract][Full Text] [Related]
20. Acceleration of cisplatin ototoxicity by perilymphatic application of 4-methylthiobenzoic acid.
Cappaert NL; Klis SF; Wijbenga J; Smoorenburg GF
Hear Res; 2005 May; 203(1-2):80-7. PubMed ID: 15855032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
